Immunophenotyping can involve numerous cell types. The following sections deal with applications of immunophenotyping in flow cytometry for five kinds of samples. Neoplasm or abnormal growth of cells ...
Are you a cell biologist, immunologist, or flow cytometrist? If so, you know how challenging it is to find quality control (QC) samples for your biomarker assays. This challenge is only heightened ...
Current chemotherapeutic regimens achieve CR in a large percentage of patients with AML. However, relapse after CR remains a significant problem. The presence of leukemic cells at levels too low to be ...
Immunophenotyping is the identification and quantitation of heterogeneous populations of cells by multi-parameter flow cytometry using a panel of fluorescently-labelled antibodies that recognize ...
The group of patients with high CD154-postive mast cells had lower overall 5-year survival rates than the low CD154-positive group. Approximately one-third of patients with Waldenström ...
The UAB Heersink School of Medicine Immunology Institute (II) is requesting applications for a voucher program designed to support experiments using high-parameter human immunophenotyping services.
ClearLLab Control Cells -a liquid preparation of stabilized human erythrocytes and leukocytes (lymphocytes monocytes and granulocytes) - the first application-specific IVD control cells for L&L ...
Immunophenotyping is a pivotal technique that combines specific antibodies with fluorescent compounds to reveal specific protein expression in cell populations to identify categorize the tagged cells.
Illustration depicting the mechanics behind flow cytometry—a technology that has revolutionized the fields of immunology and cell biology. Now, in the age of precision medicine, flow cytometry is ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Significant and distinct shifts in critical “cellular players” were seen among patients with ...
Creative Diagnostics launches new Flow Cytometry Antibody Panel for biomedical research and preclinical drug development.